Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Shuyi Chen"'
Autor:
Huo Tan, Bo Li, Xiaozhen Zeng, Yimin Chen, Zhenqian Huang, Jielun Lu, Ling Liu, Yawei Zou, Lihua Xu, Shuyi Chen
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 147:3157-3168
The expression of eukaryotic translation initiation factor-2 subunit 3 (EIF2S3) in patients with non-small cell lung and colorectal cancer is lower than that in healthy individuals. However, the functions of EIF2S3 remain unclear, and its study in le
Autor:
Xiuling Zhi, Bin Gao, Yunan Wu, Katherine Cahn, John L. Marshall, Bhaskar Kallakury, Xue Wang, Shuyi Chen, Yuriy Gusev, Krithika Bhuvaneshwar, Aiwu Ruth He, Hua Wang, Ling Lin
Publikováno v:
Theranostics
Background: Spectrin, beta, non-erythrocytic 1 (SPTBN1), an adapter protein for transforming growth factor beta (TGF-β) signaling, is recognized as a tumor suppressor in the development of hepatocellular carcinoma (HCC); however, the underlying mole
Autor:
Mo Chen, Xiuling Zhi, Huijie Wu, Jiajia Li, Xuhui Dong, Liangqing Yao, Yuan Lei, Jia Zeng, Shuyi Chen
Publikováno v:
Aging (Albany NY)
SPTBN1 plays an anticancer role in many kinds of tumors and participates in the chemotherapeutic resistance of epithelial ovarian cancer (EOC). Here, we reported that lower SPTBN1 expression was significantly related to advanced EOC stage and shorter
Autor:
Jiayu Jin, Jiajia Li, Shuyi Chen, Jieyu Guo, Mengping Jia, Dan Meng, Xiuling Zhi, Chenyang Liu, Huijie Wu, Xiangxiang Wei
Publikováno v:
European journal of pharmacology. 909
SPTBN1 (spectrin beta, non-erythrocytic 1) has been linked to tumor progression and epithelial-mesenchymal transition (EMT). However, the role of SPTBN1 has yet to be investigated in breast cancer. This study aimed to evaluate the viability, growth,
Autor:
Shuyi, Chen, Yabiao, Gao, Ping, Zhu, Xue, Wang, Linzi, Zeng, Youping, Jin, Xiuling, Zhi, Huanjun, Yang, Ping, Zhou
Publikováno v:
Frontiers in Bioscience-Landmark. 27:125
Anlotinib, a multi-target tyrosine kinase inhibitor, has significant anti-cancer effects on breast cancer (BC), lung cancer, colon cancer and ovarian cancer, but its mechanism has not been investigated in BC.The cell viability and growth of human non
Publikováno v:
Acta biochimica et biophysica Sinica. 50(9)
Clostridium difficile TcdB is a key virulence factor that causes C. difficile-associated diseases. Our previous studies have shown that recombinant full-length TcdB (rTcdB) induces cell death in CT26 cells, and rTcdB-treated CT26 cells with high immu
Publikováno v:
Acta biochimica et biophysica Sinica. 49(3)
Clostridium difficile (C. difficile) is considered to be the major cause of the antibiotic-associated diarrhea and pseudomembranous colitis in animals and humans. The prevalence of C. difficile infections (CDI) has been increasing since 2000. Two exo
Publikováno v:
Toxins, Vol 8, Iss 8, p 241 (2016)
Toxins
Toxins; Volume 8; Issue 8; Pages: 241
Toxins
Toxins; Volume 8; Issue 8; Pages: 241
Clostridium difficile toxin A (TcdA) and toxin B (TcdB) are the major virulence factors involved in C. difficile-associated diarrhea and pseudomembranous colitis. TcdA and TcdB both contain at least four distinct domains: the glucosyltransferase doma
Autor:
Jin Chen, Larisa V. Kuznetsova, Shuyi Chen, Xianrui Zhao, Stanislaus S. Wong, Jingyi Chen, Iwao Ojima
Publikováno v:
Bioconjugate Chemistry. 21:979-987
An efficient mechanism-based tumor-targeting drug delivery system, based on tumor-specific vitamin-receptor mediated endocytosis, has been developed. The tumor-targeting drug delivery system is a conjugate of a tumor-targeting molecule (biotin: vitam
Publikováno v:
Acta biochimica et biophysica Sinica. 46(11)
Clostridium difficile is the main cause of antibiotic-associated diarrhea and pseudomembranous colitis in humans and animals. Its pathogenicity is primarily linked to the secretion of two exotoxins (TcdA and TcdB). Although great progress in the toxi